4ZG logo

Median Technologies DB:4ZG Stock Report

Last Price

€3.40

Market Cap

€67.7m

7D

-0.3%

1Y

-30.8%

Updated

22 Dec, 2024

Data

Company Financials +

4ZG Stock Overview

Develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. More details

4ZG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance0/6
Financial Health0/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

Median Technologies SA Competitors

Price History & Performance

Summary of share price highs, lows and changes for Median Technologies
Historical stock prices
Current Share Price€3.40
52 Week High€7.31
52 Week Low€2.09
Beta1.49
1 Month Change0.44%
3 Month Change-22.75%
1 Year Change-30.78%
3 Year Change-78.35%
5 Year Changen/a
Change since IPO-52.45%

Recent News & Updates

Recent updates

Shareholder Returns

4ZGDE Healthcare ServicesDE Market
7D-0.3%1.1%-2.6%
1Y-30.8%-20.4%6.9%

Return vs Industry: 4ZG underperformed the German Healthcare Services industry which returned -20.4% over the past year.

Return vs Market: 4ZG underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 4ZG's price volatile compared to industry and market?
4ZG volatility
4ZG Average Weekly Movement10.7%
Healthcare Services Industry Average Movement6.1%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 4ZG's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 4ZG's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
2002250Fredrik Bragwww.mediantechnologies.com

Median Technologies SA develops and markets software products and platforms for medical image analysis in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iBiops, an end-to-end AI-powered technology software as a medical device for early diagnosis of cancers and fibrotic diseases; iSee for image analysis services in clinical trials; and iCRO, which engages in the sale of imaging services for clinical trials in oncology using software. The company was founded in 2002 and is based in Valbonne, France.

Median Technologies SA Fundamentals Summary

How do Median Technologies's earnings and revenue compare to its market cap?
4ZG fundamental statistics
Market cap€67.74m
Earnings (TTM)-€25.35m
Revenue (TTM)€22.32m

3.0x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4ZG income statement (TTM)
Revenue€22.32m
Cost of Revenue€24.67m
Gross Profit-€2.34m
Other Expenses€23.01m
Earnings-€25.35m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.37
Gross Margin-10.51%
Net Profit Margin-113.57%
Debt/Equity Ratio-138.8%

How did 4ZG perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 20:57
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Median Technologies SA is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Maria Vara FernándezBryan Garnier & Co
Dylan van HaaftenBryan Garnier & Co
Khalid DeojeeBryan Garnier & Co